{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019051","form_type":"8-K","ticker":"GLSI","cik":"0001799788","company_name":"Greenwich LifeSciences, Inc.","filed_at":"2022-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.070187+00:00","generated_at":"2026-06-24T16:54:21.549277+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Greenwich LifeSciences enters $100M ATM equity offering agreement with Jefferies","bullets":["Entered Open Market Sale Agreement with Jefferies LLC for at-the-market offering of common stock up to $100M.","Commission rate of up to 3.0% of gross proceeds; Jefferies gets customary indemnification.","Proceeds intended for general corporate purposes including GP2 clinical development, R&D, working capital.","No obligation to sell any shares; company can suspend offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019051","json":"https://secwatch.observer/filing/0001493152-22-019051.json","markdown":"https://secwatch.observer/filing/0001493152-22-019051.md","text":"https://secwatch.observer/filing/0001493152-22-019051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/0001493152-22-019051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799788/000149315222019051/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T16:54:21.549277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}